Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Cytokine response gene 8 (CR8) regulates the cell cycle G1-S phase transition and promotes cellular survival

Abstract

Cellular proliferation and survival are modulated by the expression of specific genes. Cytokine response gene 8 (CR8), which was originally cloned as an IL-2-induced gene in human T lymphocytes, encodes a basic helix–loop–helix (bHLH) transcription factor. The CR8 gene product is highly conserved among human, mouse and rat, and contains sequence motifs that distinguish it from other bHLH families. The CR8 gene is ubiquitously expressed, and CR8 gene expression is induced by both growth-promoting as well as growth-inhibitory stimuli. As bHLH proteins have been found to regulate both the G1-S phase cell cycle transition, as well as cellular survival, the effects of CR8 on these processes were investigated. Ectopic CR8 expression in asynchronous U2OS cell cultures reduces the percentage of cells in the cell cycle S phase, and also slows the entry of G1-synchronized cells into S phase. The prolonged G1 interval correlates with impaired elevation of cyclin E protein and prolonged p21 protein expression in G1. CR8 expression also protects U2OS cells from serum-withdrawal induced apoptosis. These results indicate that CR8 is an important modulator of both the G1-S phase cell cycle transition, and cellular survival.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  • Barone M, Pepperkok R, Peverali F, Philipson L . 1994 Proc. Natl. Acad. Sci. USA 91: 4985–4988

  • Beadling C, Johnson KW, Smith KA . 1993 Proc. Natl. Acad. Sci. USA 90: 2719–2723

  • Boudjelal M, Taneja R, Matsubara S, Bouillet P, Chambon P . 1997 Genes Dev. 11: 2052–2065

  • Condorelli GL, Tocci A, Botta R, Facchiano F, Testa U, Vitelli L, Valtieri M, Croce CM, Peschle C . 1997 Mol. Cell. Biol. 17: 2954–2969

  • Darzynkiewicz Z, Gong J, Juan G, Ardelt B, Traganos F . 1996 Cytometry 25: 1–13

  • Dear TN, Hainzl T, Follo M, Nehls M, Wilmore H, Matena K, Boehm T . 1997 Oncogene 14: 891–898

  • Deed JW, Bianchi SM, Atherton GT, Johnston D, Santibanez-Koref M, Murphy JJ, Norton JD . 1993 Oncogene 8: 599–607

  • Deed RW, Hara E, Atherton GT, Peters G, Norton JD . 1997 Mol. Cell. Biol. 17: 6815–6821

  • Fan W, Richter G, Cereseto A, Beadling C, Smith KA . 1999 Oncogene 18: 6573–6582

  • Fisher AL, Ohsako S, Caudy M . 1996 Mol. Cell. Biol. 16: 2670–2677

  • Florio M, Hernandez M-C, Yang H, Shu H-K, Cleveland JL, Israel MA . 1998 Mol. Cell. Biol. 18: 5435–5444

  • Gong J, Li X, Traganos F, Darzynkiewicz Z . 1994 Cell. Prolif. 27: 357–371

  • Gong J, Traganos F, Darzynkiewicz Z . 1993 Int. J. Oncol. 3: 1037–1042

  • Gullberg M, Smith KA . 1986 J. Exp. Med. 163: 270–284

  • Halevy O, Novitch BG, Spicer DB, Skapek SX, Rhee J, Hannon GJ, Beach D, Lassar AB . 1995 Science 267: 1018–1021

  • Hara E, Hall M, Peters G . 1997 EMBO J. 16: 332–342

  • Inuzuka H, Nanbu-Wakao R, Masuho Y, Muramatsu M, Tojo H, Wakao H . 1999 Biochem. Biophys. Res. Comm. 265: 664–668

  • Leroy-Viard K, Vinit M-A, Lecointe N, Jouault H, Hibner U, Romeo P-H, Mathieu-Mahul D . 1995 EMBO J. 14: 2341–2349

  • Maestro R, Dei Tos AP, Hamamori Y, Krasnokutsky S, Sartorelli V, Kedes L, Doglioni C, Beach DH, Hannon GJ . 1999 Genes Dev. 13: 2207–2217

  • Massari ME, Murre C . 2000 Mol. Cell. Biol. 20: 429–440

  • Moreno S, Nurse P . 1994 Nature 367: 236–242

  • Murre C, Bain G, van Dijk MA, Engel I, Furnari BA, Massari ME, Matthews JR, Quong MW, Rivera RR, Stuiver MH . 1994 Biochim. Biophys. Acta 1218: 129–135

  • Murre C, McCaw PS, Baltimore D . 1989 Cell 56: 777–783

  • Niculescu AB, Chen X, Smeets M, Hengst L, Prives C, Reed SI . 1998 Mol. Cell. Biol. 18: 629–643

  • Norton JD, Atherton GT . 1998 Mol. Cell. Biol. 18: 2371–2381

  • Norton JD, Deed RW, Craggs G, Sablitzky F . 1998 Trends Cell Biol. 8: 58–65

  • Peverali FA, Ramqvist T, Saffrich R, Pepperkok R, Barone MV, Philipson L . 1994 EMBO J. 13: 4291–4301

  • Prabhu S, Ignatova A, Park ST, Sun X-H . 1997 Mol. Cell. Biol. 17: 5888–5896

  • Rossner MJ, Dorr J, Gass P, Schwab MH, Nave K-A . 1997 Mol. Cell. Neurosci. 9: 460–475

  • Sasai Y, Kageyama R, Tagawa Y, Shigemoto R, Nakanishi S . 1992 Genes Dev. 6: 2620–2634

  • Shen M, Kawamoto T, Yan W, Nakamasu K, Tamagami M, Koyano Y, Noshiro M, Kato Y . 1997 Biochem. Biophys. Res. Commun. 236: 294–298

  • Sherr CJ . 1994 Cell 79: 551–555

  • Sherr CJ . 1996 Science 274: 1672–1677

  • Sun H, Taneja R . 2000 Proc. Acad. Sci. USA 97: 4058–4063

Download references

Acknowledgements

This work was supported by National Institutes of Health, NIAID grants □num;RO1 A1 32031-24 and 1RO1 Al44207-O1A1.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Beadling, C., Cereseto, A., Fan, W. et al. Cytokine response gene 8 (CR8) regulates the cell cycle G1-S phase transition and promotes cellular survival. Oncogene 20, 1771–1783 (2001). https://doi.org/10.1038/sj.onc.1204212

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204212

Keywords

This article is cited by

Search

Quick links